The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery
Open accessAbstract
As the field of biotechnology has advanced, oral protein delivery has also made significant progress. Oral delivery is the most common method of drug administration with high levels of patient acceptance. Despite the preference of oral delivery, administration of therapeutic proteins has been extremely difficult. Increasing the bioavailability of oral protein drugs to the therapeutically acceptable level is still a challenging goal. Poor membrane permeability, high molecular weight, and enzymatic degradation of protein drugs have remained unsolved issues. Among diverse strategies, nanotechnology has provided a glimpse of hope in oral delivery of protein drugs. Nanoparticles have advantages, such as small size, high surface area, and modification using functional groups for high capacity or selectivity. Nanoparticles with peptidic ligands are especially worthy of notice because they can be used for specific targeting in the gastrointestinal (GI) tract. This article reviews the transport mechanism of the GI tract, barriers to protein absorption, current status and limitations of nanotechnology for oral protein delivery system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
Hersel, U., Dahmen, C., & Kessler, H. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00343-0 · Cited by 2,582
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Smith, G. P., & Petrenko, V. A. (1997) · Chemical Reviews · doi:10.1021/cr960065d · Cited by 1,548
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
What should be called a lectin?
GOLDSTEIN, I. J., HUGHES, R. C., MONSIGNY, M., OSAWA, T., & SHARON, N. (1980) · Nature · doi:10.1038/285066b0 · Cited by 883
Advantages of RGD peptides for directing cell association with biomaterials
Bellis, S. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.029 · Cited by 745
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00152-1 · Cited by 680
Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634
Powell, D. W. (1981) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1981.241.4.g275 · Cited by 622
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Adessi, C., & Soto, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606731 · Cited by 614
Quintanar-Guerrero, D., Allémann, E., Fessi, H., & Doelker, E. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809108571 · Cited by 589
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Elastin: molecular description and function
Debelle, L., & Tamburro, A. M. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00098-3 · Cited by 545
REGULATION OF THE MOVEMENT OF SOLUTES ACROSS TIGHT JUNCTIONS
Madara, J. L. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.143 · Cited by 523
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Koivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477
A New Approach to the Oral Administration of Insulin and Other Peptide Drugs
Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., Williams, F., & Neckers, D. C. (1986) · Science · doi:10.1126/science.3526553 · Cited by 469
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection.
Allen, A., & Garner, A. (1980) · Gut · doi:10.1136/gut.21.3.249 · Cited by 363
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
M Cells in Peyer's Patches of the Intestine
Gebert, A., Rothkötter, H.-J., & Pabst, R. (1996) · International Review of Cytology · doi:10.1016/s0074-7696(08)61346-7 · Cited by 320
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
Emerich, D. F., & Thanos, C. G. (2006) · Biomolecular Engineering · doi:10.1016/j.bioeng.2006.05.026 · Cited by 312
Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
Crater, J. S., & Carrier, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000137 · Cited by 302
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Enzymatic barriers for GI peptide and protein delivery.
Woodley, J. F. (1994) · PubMed · Cited by 291
Gastrointestinal absorption of drugs: methods and studies
Barthe, L., Woodley, J., & Houin, G. (1999) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00334.x · Cited by 290
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Zhang, N., Ping, Q., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286
LIU, J., GONG, T., WANG, C., ZHONG, Z., & ZHANG, Z. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.009 · Cited by 282
Nanosphere based oral insulin delivery
Carino, G. P., Jacob, J. S., & Mathiowitz, E. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00247-3 · Cited by 278
Wagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Self-citationBinding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia
McClean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, N., Ramtoola, Z., & Brayden, D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10007-0 · Cited by 260
Black, R. L. (1984) · Military Medicine · doi:10.1093/milmed/149.3.161a · Cited by 247
Lectin-mediated mucosal delivery of drugs and microparticles
Clark, M. A., Hirst, B. H., & Jepson, M. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00070-3 · Cited by 236
Galindo-Rodriguez, S. A., Allemann, E., Fessi, H., & Doelker, E. (2005) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v22.i5.10 · Cited by 231
Paracellular Ion Channel at the Tight Junction
Tang, V. W., & Goodenough, D. A. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74975-3 · Cited by 229
Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters
Pappenheimer, J. R. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209146 · Cited by 220
Mamaeva, V., Rosenholm, J. M., Bate-Eya, L. T., Bergman, L., Peuhu, E., Duchanoy, A., Fortelius, L. E., Landor, S., Toivola, D. M., Lindén, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.105 · Cited by 220
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents
Serra, L., Doménech, J., & Peppas, N. A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.022 · Cited by 217
Kerss, S., Allen, A., & Garner, A. (1982) · Clinical Science · doi:10.1042/cs0630187 · Cited by 203
Surface-engineered nanoparticles for multiple ligand coupling
Gref, R., Couvreur, P., Barratt, G., & Mysiakine, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00348-x · Cited by 197
Maloy, K. J., Donachie, A. M., O’Hagan, D. T., & Mowat, A. M. (1994) · PubMed Central · Cited by 183
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
The challenge of proteolytic enzymes in intestinal peptide delivery
Langguth, P., Bohner, V., Heizmann, J., Merkle, H. P., Wolffram, S., Amidon, G. L., & Yamashita, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01586-6 · Cited by 170
A novel method for surface modification to promote cell attachment to hydrophobic substrates
Neff, J. A., Caldwell, K. D., & Tresco, P. A. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980615)40:4<511::aid-jbm1>3.0.co;2-i · Cited by 167
Systemic delivery of peptides and proteins across absorptive mucosae.
Sayani, A. P., & Chien, Y. W. (1996) · PubMed · Cited by 161
Flux Measurements across Caco-2 Monolayers May Predict Transport in Human Large Intestinal Tissue
Rubas, W., Cromwell, M. E. M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., & Mrsny, R. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950267+ · Cited by 160
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Shakweh, M., Ponchel, G., & Fattal, E. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.141 · Cited by 159
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Human Intestinal M Cells Display the Sialyl Lewis A Antigen
Giannasca, P. J., Giannasca, K. T., Leichtner, A. M., & Neutra, M. R. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.946-953.1999 · Cited by 155
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.013 · Cited by 152
Yoo, M. K., Kang, S., Choi, J.-H., Park, I., Na, H. S., Lee, H., Kim, E.-B., Lee, N.-K., Nah, J., Choi, Y.-J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.059 · Cited by 150
Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting
Florence, A. T. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693706 · Cited by 147
Bai, J. P. F., & Amidon, G. L. (1992) · Pharmaceutical Research · doi:10.1023/a:1015885823793 · Cited by 145
Protein drug oral delivery: The recent progress
Lee, H. J. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976925 · Cited by 143
MORISHITA, M., Morishita, I., TAKAYAMA, K., Machida, Y., & NAGAI, T. (1993) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.16.68 · Cited by 141
JEONG, Y., SEO, S., Park, I., Lee, H., Kang, I., Akaike, T., & CHO, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.027 · Cited by 138
Coupling Tumor Necrosis Factor-α with αV Integrin Ligands Improves Its Antineoplastic Activity
Curnis, F., Gasparri, A. M., Sacchi, A., Longhi, R., & Corti, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1753 · Cited by 138
Berry, C. C., Charles, S. W., Wells, S., Dalby, M. J., & Curtis, A. S. G. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.042 · Cited by 138
Identification of receptor ligands with phage display peptide libraries.
Koivunen, E., Arap, W., Rajotte, D., Lahdenranta, J., & Pasqualini, R. (1999) · PubMed · Cited by 137
Jani, P. U., Florence, A. T., & McCarthy, D. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90162-u · Cited by 136
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
Tomita, M., Hayashi, M., Horie, T., Ishizawa, T., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015992819290 · Cited by 133
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
Kompella, U. B., & Lee, V. H. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00137-x · Cited by 131
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Pharmacokinetic Considerations of New Insulin Formulations and Routes of Administration
Hoffman, A., & Ziv, E. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733040-00004 · Cited by 127
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis
Kim, W. J., Yockman, J. W., Lee, M., Jeong, J. H., Kim, Y., & Kim, S. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.016 · Cited by 126
Lipophilic prodrugs designed for intestinal lymphatic transport
Charman, W. N., & Porter, C. J. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00105-g · Cited by 124
Bioadhesion by Means of Specific Binding of Tomato Lectin
Lehr, C., Bouwstra, J. A., Kok, W., Noach, A. B. J., de Boer, A. G., & Junginger, H. E. (1992) · Pharmaceutical Research · doi:10.1023/a:1015804816582 · Cited by 122
Primard, C., Rochereau, N., Luciani, E., Genin, C., Delair, T., Paul, S., & Verrier, B. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.021 · Cited by 122
Intestinal translocation of particulates — implications for drug and antigen delivery
O’Hagan, D. T. (1990) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(90)90020-s · Cited by 122
Oral Controlled Release Technology for Peptides: Status and Future Prospects
Fix, J. A. (1996) · Pharmaceutical Research · doi:10.1023/a:1016008419367 · Cited by 121
Lectin-mediated transport of nanoparticles across Caco-2 and OK cells
Russell-Jones, G. J., Veitch, H. S., & Arthur, L. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00254-9 · Cited by 116
Almeida, A. J., Alpar, H. O., & Brown, M. R. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05532.x · Cited by 116
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Yin, Y.-S., Chen, D., Qiao, M., Wei, X., & Hu, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.024 · Cited by 109
Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice
Oldenborg, P. (2002) · Blood · doi:10.1182/blood.v99.10.3500 · Cited by 108
The importance of gastrointestinal uptake of particles in the design of oral delivery systems
Lavelle, E. C., Sharif, S., Thomas, N. W., Holland, J., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00048-c · Cited by 103
(B) Mechanisms of peptide and protein absorption
Burton, P. S., Conradi, R. A., & Hilgers, A. R. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90014-4 · Cited by 102
WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells
Weissenböck, A., Wirth, M., & Gabor, F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.025 · Cited by 101
In vitro Selection of a Peptide with High Selectivity for Cardiomyocytes In vivo
McGuire, M. J., Samli, K. N., Johnston, S. A., & Brown, K. C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.029 · Cited by 101
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
Arosio, D., Manzoni, L., Araldi, E. M. V., & Scolastico, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100448r · Cited by 96
Enhancement of Colonic Drug Absorption by the Paracellular Permeation Route
Tomita, M., Shiga, M., Hayashi, M., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015999309353 · Cited by 93
Transcellular Delivery of an Insulin-Transferrin Conjugate in Enterocyte-like Caco-2 Cells
Shah, D., & Shen, W. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601400 · Cited by 92
Recent Advances in Intestinal Macromolecular Drug Delivery via Receptor-Mediated Transport Pathways
Swaan, P. W. (1998) · Pharmaceutical Research · doi:10.1023/a:1011908128045 · Cited by 91
Wang, W. (1996) · Journal of drug targeting · doi:10.3109/10611869608995624 · Cited by 85
Ezpeleta, I., Arangoa, M. A., Irache, J. M., Stainmesse, S., Chabenat, C., Popineau, Y., & Orecchioni, A. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00232-x · Cited by 85
Challenges in Delivery of Therapeutic Genomics and Proteomics
(2011) · Elsevier eBooks · doi:10.1016/c2010-0-65663-x · Cited by 85
The effect of gastro-intestinal mucus on drug absorption
MacAdam, A. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90010-2 · Cited by 83
Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles
Gao, X., Wang, T., Wu, B., Chen, J., Chen, J.-Y., Yue, Y., Dai, N., Chen, H., & Jiang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.077 · Cited by 80
Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand
Lee, G. Y., Kim, J.-H., Oh, G. T., Lee, B.-H., Kwon, I. C., & Kim, I. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.010 · Cited by 79
Ray, A. L., Vert, M., Gautier, J. C., & Benoît, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90003-5 · Cited by 74
PR_b-Targeted PEGylated Liposomes for Prostate Cancer Therapy
Demirgöz, D., Garg, A., & Kokkoli, E. (2008) · Langmuir · doi:10.1021/la801961r · Cited by 68
Aoki, Y., Morishita, M., Asai, K., Akikusa, B., Hosoda, S., & Takayama, K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6137-z · Cited by 67
Bioadhesion of Lectin-Latex Conjugates to Rat Intestinal Mucosa
Irache, J. M., Durrer, C., Duchêne, D., & Ponchel, G. (1996) · Pharmaceutical Research · doi:10.1023/a:1016405126656 · Cited by 65
Targeting of mucosal vaccines to Peyer's patch M cells.
Frey, A. B., & Neutra, M. R. (1997) · PubMed · Cited by 63
Degradation of proteins by guinea pig intestinal enzymes
Ikesue, K., Kopečková, P., & Kopec̆ek, J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90404-4 · Cited by 61
Use of fluorescence imaging to investigate the structure and function of intestinal M cells
BUDA, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.014 · Cited by 59 · cited 1×
“M cells take upmacromolecules, particles and microorganisms by adsorptive endocytosis via clathrin-coated pits and vesicles, fluid phase endocytosis and phagocytosis [28].”
Preparation and characterization of lectin-latex conjugates for specific bioadhesion
Irache, J. M., Durrer, C., Duchêne, D., & Ponchel, G. (1994) · Biomaterials · doi:10.1016/0142-9612(94)90114-7 · Cited by 59
Hebden, J. M., WILSON, C. G., Spiller, R. E., Gilchrist, P. J., Blackshaw, E., Frier, M. E., & Perkins, A. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018948102778 · Cited by 57
Baker, M. E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01346-5 · Cited by 55
In vitro identification of targeting ligands of human M cells by phage display
Fiévez, V., Plapied, L., Plaideau, C., Legendre, D., Rieux, A. D., Pourcelle, V., Freichels, H., Jérôme, C., Marchand, J., Véronique Préat, A., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.023 · Cited by 52
Nanoparticulate Systems in Drug Delivery and Targeting
Kreuter, J. (1995) · Journal of drug targeting · doi:10.3109/10611869509015940 · Cited by 47
Oral Delivery of Proteins and Peptides
Patel, G., & Misra, A. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384964-9.00010-4 · Cited by 41
Peptide-Mediated Targeting of the Islets of Langerhans
Samli, K. N., McGuire, M. J., Newgard, C. B., Johnston, S. A., & Brown, K. C. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2103 · Cited by 40
Regulation of Gastrointestinal Function
Herdt, T. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-55227-1.00027-2 · Cited by 28
Kataoka, K., Tabata, J., Yamamoto, M., & TOYOTA, T. (1989) · Archivum histologicum japonicum · doi:10.1679/aohc.52.81 · Cited by 27
Aminopeptidase Activity in the Jejunal and Heal Peyer's Patches of the Albino Rabbit
Hayakawa, E., & Lee, V. H. L. (1992) · Pharmaceutical Research · doi:10.1023/a:1015800615674 · Cited by 26
Andersson, M., Fromell, K., Gullberg, E., Artursson, P., & Caldwell, K. D. (2005) · Analytical Chemistry · doi:10.1021/ac050631h · Cited by 26
Ligand-mediated tissue specific drug delivery
Hussain, N. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00066-1 · Cited by 20
Gullberg, E. (2005) · Uppsala University Publications (Uppsala University) · Cited by 10
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Metadata
- Authors
- Yun, Y., Cho, Y. W., & Park, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 65
- Issue
- 6
- Pages
- 822-832
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2040243871
- Cited by
- 444
- References
- 121
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.